The chemical class known as Cypt9 Activators encompasses a diverse range of compounds that interact with cellular signaling pathways and regulatory mechanisms, which can lead to the activation of the Cypt9 protein. These activators can be defined by their ability to modulate intracellular processes that either directly or indirectly result in the increased activity of Cypt9. This modulation can occur through various biochemical routes, including alterations in enzyme catalytic activity, changes in gene expression, or modifications of protein-protein interactions within the cell. The activators can act at multiple levels of cellular function, from the plasma membrane through to the nucleus, impacting processes such as signal transduction, transcriptional control, and post-translational modifications of proteins.
The activators within this chemical class can influence the activity of Cypt9 by engaging with different molecular targets. For instance, some might activate kinases or inhibit phosphatases, leading to a change in phosphorylation patterns that can affect Cypt9 activity. Others can bind to receptors or ion channels, initiating cascades of events that lead to the release of secondary messengers and subsequent activation of Cypt9. Additionally, some activators can alter the redox state of the cell or modulate the availability of metal ions, which in turn can have an impact on the structural conformation and function of Cypt9. Overall, the chemical activators that fall under the category of Cypt9 Activators are characterized by their ability to engage with and modulate cellular pathways, resulting in the enhanced activity of the Cypt9 protein within the cellular environment.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Known as a protein kinase inhibitor, at low concentrations, it alters kinase activity and could possibly activate Cypt9. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Inhibits protein tyrosine phosphatases, upregulating tyrosine kinase pathways that could possibly activate Cypt9. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC), which could possibly activate Cypt9 through related signaling pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium levels, activating calcium-dependent proteins that could possibly activate Cypt9. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Inhibits histone deacetylases, altering gene expression, which could possibly activate Cypt9. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, which through kinase signaling networks, could possibly activate Cypt9. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK in the MAPK/ERK pathway, leading to changes in phosphorylation states that could possibly activate Cypt9. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Inhibits the SERCA pump leading to increased cytosolic calcium, which could possibly activate Cypt9. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Serves as a cofactor for enzymes and could influence the function of metalloproteins, which could possibly activate Cypt9. | ||||||